Elsevier Pharmacovigilance Survey
Innovation and Performance: What’s literature got to do with it?

Pharmaceutical companies must uphold patient safety and manage pharmacovigilance regulatory compliance risks.

Identifying adverse events and safety signals from multiple sources quickly enough so companies can react to it continues to be a challenge, especially as the volume of available literature and data continues to increase.

How are industry leaders driving business performance amidst big data? What are the leading practices for harnessing data to create innovative and new drugs and treatments? What are the common challenges and bottlenecks?

Help us deliver a comprehensive report by participating in a survey on current industry practices.

Participants of the survey will receive a free copy of key findings from the survey in June 2017. The survey should take approximately 15 minutes to complete.

All survey responses are anonymous so that responses are not associated with specific company names.

To receive the free report, you must complete the survey and be a professional with job responsibilities related to pharmacovigilance in a pharmaceutical company. A valid work email is required to receive the report.

Elsevier's R&D Solutions for Pharmacovigilance


Promote efficiency and organizational compliance by centralizing the discovery of adverse event information and automating information monitoring and triage in a scalable environment.

Learn more about QUOSA PV


Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium


Improve literature monitoring for adverse events with the world’s most comprehensive biomedical literature database.
Learn more about Embase

Professional Services

Streamline literature monitoring for adverse events by validating search strategies and implementing solutions for literature triage and review.  
Learn more about Professional Services